Schulz Fran has filed 3 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 21950 shares of Senti Biosciences, Inc. ($SNTI) on June 25, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 25, 2025 | Senti Biosciences, Inc. | $SNTI | Schulz Fran | Not found | A | Stock Option (Right to Buy) | 21950 | $0.00 | 21,950.0000 | 26,004,366 | 9999.99% | 0.08% |
| March 7, 2025 | Senti Biosciences, Inc. | $SNTI | Schulz Fran | Director | A | Stock Option (Right to Buy) | 43900 | $0.00 | 43,900.0000 | 4,829,035 | 9999.99% | 0.91% |
| Dec. 9, 2024 | Senti Biosciences, Inc. | $SNTI | Schulz Fran | Director | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 4,586,957 | 9999.99% | 0.27% |